Clinical trial
Blood Detection of EGFR Mutation For Iressa Treatment
NCT02282267 is registered in ClinicalTrials.gov with Peking University Cancer Hospital & Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Blood Detection of EGFR Mutation For Iressa Treatment
- Lead sponsor
- Peking University Cancer Hospital & Institute
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 31, 2014
- Completion date
- February 28, 2018
- Enrollment
- 188 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung adenocarcinoma